A critique of instruments and methods to detect, diagnose, and rate delirium

Journal of Pain and Symptom Management

Volumn 10, Issue 1, 1995, Pages 35-77

  Smith, Mark J ^a   Breitbart, William S ^a   Platt, Meredith M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

cognitive; Delirium; diagnosis; evaluation; instruments; psychological tests; psychometrics; rating; screening; severity

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; ALCOHOL; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BETA ENDORPHIN; CALCIUM; CHLORPROMAZINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CORTICOTROPIN; CYCLIC GMP; GLUTAMIC ACID; HALOPERIDOL; LORAZEPAM; LYSERGIDE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PHENCYCLIDINE; PHOSPHATIDYLINOSITOL; QUINUCLIDINYL BENZILATE; SEROTONIN;

ARTICLE; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; DELIRIUM; DIAGNOSIS; DRAWING; ELECTROENCEPHALOGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTELLIGENCE TEST; MEMORY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PSYCHOLOGIC TEST; PSYCHOMETRY; RATING SCALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

COGNITION DISORDERS; DELIRIUM; EVALUATION STUDIES; HUMAN; NEUROPSYCHOLOGICAL TESTS; PEDIATRICS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS;

EID: 0028914128     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/0885-3924(94)00066-T     Document Type: Article

References (237)

1. Delirium (Acute Confusional States)
2. Delirium and dementia: diagnostic criteria and fatality rates
3. Neuropsychiatric Assessment of Liver Transplantation Candidates: Delirium and Other Psychiatric Disorders
4. Post-operative delirium
5. Pharmacologic management of delirium in medically hospitalized AIDS patients
6. The prevalence of psychiatric disorders among cancer patients
7. Delirium and dementia
8. Mental disorders in cancer patients
9. Delirium and exogenous metabolic brain disease
10. Delirium in cancer patients
11. Limits of the “mini mental state” as a screening test for dementia and delirium among hospital patients
12. Adverse consequences of hospitalization in the elderly
13. Psychological aspects of cancer in the elderly
14. The cancer patient with pain: psychiatric complications and their management
15. A prospective study of delirium in hospitalized elderly
16. Delirium in terminally ill cancer patients
17. Delirium
18. Proposals for revision of diagnostic criteria for delirium
19. An empirical study of diagnostic criteria for delirium
20. CNS arousal systems: possible role in delirium
21. The neuropsychology of schizophrenia
22. The cellular basis of delirium and its relevance to age-related disorders including Alzheimer's disease
23. Treatment of severe, refractory agitation with a Haldol drip
24. Management of delirium in terminally ill AIDS patients
25. Using intravenous haloperidol to control delirium
26. Intravenous haloperidol-lorazepam therapy for delirium
27. Efficacy of neuroleptics for hypoactive delirium
28. Physostigmine reversal of drug-induced paradoxical excitement
29. Delirium
30. Neuropsychiatric complications in burn patients
31. A clinical study of delirium in children and adolescents
32. Dementia and delirium
33. Pediatric delirium: underdiagnosed and undertreated?
34. Delirium
35. Transient cerebral affections
36. Topical diphenhydramine toxicity
37. Toxic delirium possibly caused by loperamide
38. Autoimmune Addison's disease and thyrotoxic thyroiditis presenting as encephalopathy in twins
39. Acute alcohol withdrawal syndrome
40. Development of a rating scale for quantitative measurement of the alcohol withdrawal syndrome
41. Characterization of the DSM-III-R criteria for uncomplicated alcohol withdrawal
42. Clinical and laboratory differentiation of alcohol withdrawal syndrome (“predelirium”) and alcoholic delirium
43. Screening devices for diminished cognitive capacity
44. Delirium in surgical patients under intensive care
45. Corticosteroids in cancer: neuropsychiatric complications
46. New-onset psychosis in HIV-infected patients
47. Delirium in the medically ill elderly: operationalizing DSM-II criteria
48. The neurobehavioral cognitive status examination: comparison with the Cognitive Capacity Screening Examination and the Mini Mental Status Examination in a neurosurgical population
49. Acute confusional state and acute agitated delirium: occurrence after infarction in the right middle cerebral artery territory
50. A review of screening instruments for assessing cognition and mental status in older adults
51. A rapidly administered, easily remembered mental status evaluation: FROMAJE
52. A new rating scale for dementia syndromes
53. The Brief Cognitive Rating Scale (BCRS): findings in primary degenerative dementia
54. VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE
55. Clock Drawing in the screening assesment of cognitive impairment in an ambulatory care setting: a preliminary report
56. A symptom rating scale for delirium
57. The clinical utility of the hand-held tachistoscope
58. A new tool for consultation-liaison funding: modified DGRs to reflect psychiatric comorbidity
59. Screening for delirium on a general medical ward: the tachistoscope and a global accessibility rating
60. Clock drawing in Alzheimer's disease
61. Screening for Alzheimer's disease by clock drawing
62. Brief objective measures for the determination of mental status in the aged.
63. The face-hand test as a diagnostic sign of organic mental syndrome
64. The relationship of mental and physical status in institutionalized aged persons.
65. Brain function, intellectual impairment and education in the aged
66. Comparison of two brief tests of organic impairment, the MSQ & the SPMSQ
67. The assessment of the mental status of elderly hospital patients using a simple questionnaire
68. A Short Mental Status Questionnaire
69. Two mental status assessment methods: an evaluation
70. Mental status and memory assessment as predictors of dementia
71. A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients
72. A clinical comparison of tests of organicity in elderly patients
73. Validity of the short portable mental status questionnaire with elderly psychiatric patients
74. Relationship between Bender designs and basic living skills of geriatric psychiatric patients
75. Mental status tests and the capacity for self-care
76. Validity study of the short portable mental status questionnaire for the elderly
77. Short portable mental status questionnaire as a screening test for dementia and delirium among the elderly
78. “Mini mental state:” a practical method of grading the cognitive state of patients for the clinician
79. The mini-mental state examination: a comprehensive review
80. Psychopathology of dementia: implications for neuropathology
81. Mini mental state examination in neurological patients
82. The mini mental state examination
83. The 12-month reliability of the mini-mental state examination
84. Reliability and validity of the mini-mental state exam in neurologically intact elderly
85. The reliability and validity of the mini-mental state in a British community survey
86. Cognitive Impairment Among Elderly Adults in Shanghai, China
87. Cognitive impairment and functional disability in the absence of psychiatric diagnosis
88. Screening for dementia and delirium using an adapted Folstein Mini-Mental State Examination
89. Bedside cognitive screening instruments: a critical assessment
90. Validation of a short orientation-memory-concentration test of cognitive impairment
91. The consortium to establish a registry for Alzheimer's disease (CERAD). Part 1. Clinical and neuropsychological assessment of Alzheimer's disease
92. The mini-mental state test and computerized tomography
93. Psychiatric screening on a neurological ward
94. Post-operative delirium
95. EEG spectral analysis in delirium
96. Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of Alzheimer's type: preliminary findings
97. The relationship between severity of depression, cognitive dysfunction, and age in medical inpatients.
98. The relationship between pre-operative anxiety and post-operative delirium
99. Methodological issues in screening for dementia: the problem of education adjustment
100. Predicting performance on the mini mental state examination
101. Use of the mini mental state examination (MMSE) in a community population of mixed ethnicity
102. Cross cultural studies of dementia: a comparison of Mini Mental State examination performance in Finland and China
103. Diagnosing dementia: univariate and multivariate analyses of the mental status examination
104. Depression, intellectual impairment and Parkinson's disease
105. The mini mental state examination in the early diagnosis of Alzheimer's dementia
106. Reliability of a standardized mini-mental state examination compared with the traditional mini-mental state examination
107. Alzheimer's dementia: performance on the mini-mental state examination
108. Reliability and validity of mental status questionnaires in elderly hospitalized patients
109. Screening for organic mental syndromes in the medically ill
110. Screening for cognitive deficits in a sample of hospitalized geriatric patients: a re-evaluation of a brief mental status questionnaire
111. Detection of cognitive deficits by a brief mental status examination: the cognitive capacity screening examination, a reappraisal and a review
112. Cognitive impairment on a rehabilitation service
113. The association between cognitive measures of dementia and of senile change in the cerebral grey matter of elderly subjects
114. Psychological testing in the differential diagnosis of dementias
115. Comparison of rate of annual change of mental status score in four independent studies of patients with Alzheimer's disease
116. Alzheimer's disease: a correlation analysis of the Blessed information-memory-concentration test and the mini-mental state exam
117. Toxic and metabolic encephalopathies in long-term care patients
118. Brief screening tests versus clinical staging in senile dementias of the Alzheimer type
119. Comparison of two screening tests in Alzheimer's disease: the correlation and reliability of the mini mental state examination and the modified Blessed test
120. A comparative evaluation of the short orientation memory concentration test of cognitive impairment.
121. The development and initial validation of a sensitive bedside cognitive screening test
122. High sensitivity cognitive screen
123. The short test of mental status
124. Mental status examination for organic mental syndromes in the elderly
125. A Standardized Memory Scale for Clinical Use
126. Evaluation of a mental test score for assessment of mental impairment in the elderly
127. The abbreviated mental test: its use and validity
128. Evaluation of a ten-question mental test in the institutionalized elderly
129. Confusion ratings and abbreviated mental test performance: a comparison
130. Correlation between the 37-item mental test score and abbreviated 10-item mental test score by psychogeriatric day patients
131. Development of an instrument for early ascertainment of psychiatric disorder in elderly community residents: a pilot study
132. Learning, retention, and conceptual usage in elderly patients with memory disorder
133. Comparison of the sensitivity of three instruments for the detection of cognitive decline in elderly living at home
134. Memory deficits in chronic alcoholics: continuities between the “intact” alcoholic and the alcoholic Korsakoff patients
135. Cognitive loss and recovery in long-term alcohol abusers
136. Utility of the four-word short-term memory test as a measure of memory impairment
137. The neurobehavioral cognitive status examination: a brief but differentiated approach to cognitive assessment
138. Prospective cognitive assessment of stroke patients before inpatient rehabilitation
139. Brief assessment of cognitive impairment in patients with stroke
140. Delirium: a test of the DSM-III criteria on medical inpatients
141. Using DSM-III criteria to diagnose delirium in elderly general medical patients
142. Acute confusion in elderly medical patients
143. Dementia Among Medical Inpatients
144. Clarifying confusion: the confusion assessment method
145. The delirium symptom interview: an interview for the detection of delirium symptoms in hospitalized patients
146. Mental status change in the elderly: recognizing and treating delirium
147. Review of instruments and techniques used to detect delirium
148. Delirium: the occurrence and persistence of symptoms among elderly hospitalized patients
149. Confusion: testing versus observation
150. Continuing Care Retirement Communities: Self-Insuring for Long-Term Care
151. Response to “Mental status change in the elderly: recognizing and treating delirium,” by CR Morency
152. The NEECHAM Confusion Scale: relationship to clinical indicators of acute confusion in hospitalized elders
153. Study of cognitive functioning in a medical population
154. Computed tomography findings in delirium
155. Delirium and the DST in the aged
156. Association of low serum anticholinergic levels and cognitive impairment in elderly presurgical patients
157. Coefficient alpha and the internal structure of tests
158. The memorial delirium severity assessment scale (MDAS): psychometric characteristics
159. Morphine-induced acute confusional states: a retrospective analysis
160. Postoperative confusion following anesthesia in elderly patients treated for femoral neck fractures
161. Acute confusional states in elderly patients treated for femoral fracture
162. Delirium, a syndrome of cerebral insufficiency
163. Delirium: phenomenologic and etiologic subtypes
164. The use of the electroencephalogram in the diagnosis of delirium
165. Some biochemical and electroencephalographic changes in delirium tremens
166. Anticholinergic drug-induced delirium: experimental modification, quantitative EEG and behavioral correlations
167. Role of the EEG in evaluating central nervous system dysfunction
168. Structural determinants of electroencephalographic findings in acute hemispheric lesions
169. A prospective study of delirium in elderly patients admitted to a psychiatric hospital
170. EEG power spectrum and confusion in the elderly
171. Value of EEG in acute confusional states
172. EEG changes associated with burn delirium
173. Quantitative measurement of brain electrical activity in delirium
174. Conventional and quantitative EEG in the diagnosis of delirium among the elderly
175. Dietary protein in the genesis of hepatic coma
176. Hepatic coma: the EEG pattern
177. The electroencephalogram in liver disease
178. Relationship between post-cardiotomy delirium, clinical neurological changes, and EEG abnormalities
179. The effect of alcohol on the electroencephalogram (brain waves)
180. DELIRIUM
181. The effects of atropine on the electroencephalogram and behavior in man
182. An animal model for delirium
183. Utility of EEG in delirium: past views and current practice
184. Computed tomography and aging of the brain
185. NMR relaxation time of the brain during alcohol withdrawal and its lack of relationship with symptom severity
186. T1 and T2 relaxation time estimates and brain measures during withdrawal in alcoholic men
187. Brain magnetic resonance imaging findings in ECT-induced delirium
188. Radiologic correlates of antidepressant-induced delirium: the possible significance of basal-ganglia lesions
189. Cerebral blood flow and amino acid metabolism in chronic alcoholism
190. Cerebral blood flow during delirium tremens and related clinical states studied with xenon-133 inhalation tomography
191. Regional blood flow during alcohol withdrawal
192. Cerebral blood flow and metabolism in patients with delirium tremens
193. The role of SPECT brain imaging in assessing psychopathology in the medically ill
194. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model
195. The amnesic properties of hyoscine and atropine in pre-anesthetic medication
196. The relationship of serum anticholinergic activity to mental status performance in an elderly nursing home population
197. Anticholinergic effects of drugs commonly prescribed for the elderly: potential means for assessing risk of delirium
198. Risk factors for delirium in hospitalized elderly
199. Cholinergic deficiency and frontal dysfunction in Parkinson's disease
200. A clinical method of estimating risk of drug-induced delirium
201. Association of postoperative delirium with raised serum levels of anticholinergic drugs
202. Serum levels of anticholinergic drugs and impaired recent memory in chronic schizophrenic patients
203. Post ECT confusional states associated with elevated serum anticholinergic levels
204. Self-care capacity and anticholinergic drug levels in nursing home patients
205. Psychopharmacologic and clinical correlates of attention in chronic schizophrenia
206. Memory deficits and anticholinergic levels in chronic schizophrenia
207. Association of elevated plasma anticholingeric levels with delirium in surgical patients
208. Benzodiazepine-induced and anticholinergic-induced delirium in the elderly
209. A longitudinal study of cerebrospinal fluid acetylcholinesterase in delirium: changes at the acute stage and at one-year follow-up
210. Physostigmine: its use in acute anticholinergic syndrome with antidepressant and anti-parkinsonian drugs
211. Physostigmine: recent pharmacologic data and their significance for practical use
212. Alterations in cerebrospinal fluid somatostatin-like immunoreactivity in neuropsychiatric disorders
213. CSF somatostatin in affective illness
214. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease
215. Cerebrospinal fluid somatostatin in delirium
216. Cerebrospinal fluid somatostatin in delirium. II. Changes at the acute stage and at one-year follow-up
217. Clinical studies of the endogenous opioid system
218. A longitudinal study of beta-endorphin-like immunoreactivity in delirium. II. Changes at the acute stage and at one-year follow-up
219. Beta-endorphin, cortisol, and postoperative delirium: a preliminary report
220. Psychosomatic aspects of catecholamine depression
221. The calcium channel antagonist nifedipine causes confusion when used to treat opiate withdrawal in morphine-dependent patients
222. Biochemical investigations into the alcoholic delirium: alteration of biogenic amines